Coherus Oncology, Inc.
CHRS
$1.13
-$0.04-3.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -56.57M | -50.70M | -10.75M | -12.92M |
| Total Depreciation and Amortization | -- | 1.05M | 1.03M | 1.55M | 1.19M |
| Total Amortization of Deferred Charges | -- | -- | 4.16M | -- | -- |
| Total Other Non-Cash Items | -- | 18.84M | 19.57M | 8.72M | -2.80M |
| Change in Net Operating Assets | -- | 10.86M | 54.54M | -61.53M | 74.26M |
| Cash from Operations | -- | -25.83M | 28.61M | -62.02M | 59.73M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00 | 0.00 | -- |
| Other Investing Activities | -- | -17.49M | -542.00K | 444.00K | 27.66M |
| Cash from Investing | -- | -17.49M | -542.00K | 444.00K | 27.66M |
| Total Debt Issued | -- | -- | 0.00 | -141.00K | 37.12M |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -260.39M |
| Issuance of Common Stock | -- | -- | 241.00K | 0.00 | 633.00K |
| Repurchase of Common Stock | -- | -264.00K | -10.00K | -10.00K | -1.71M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -16.00K | 36.42M |
| Cash from Financing | -- | -264.00K | 231.00K | -167.00K | -187.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -43.58M | 28.30M | -61.74M | -100.54M |